Insider · CIK 0001298146
Brian JG Pereira
Files at KALV (KalVista Pharmaceuticals, Inc.), PROK (PROKIDNEY CORP.). First filing Nov 14, 2025, latest Nov 14, 2025.
Brian JG Pereira files SEC Form 4 as director at PROK (PROKIDNEY CORP.), and also at KALV (KalVista Pharmaceuticals, Inc.). Since Nov 14, 2025, Brian JG Pereira has reported 0 open-market buys worth $0 and 1 open-market sell worth $1.9M, the latest filed on Nov 14, 2025.
A track record needs three past buys with six months of prices behind them; Brian JG Pereira has 0, so none is measured yet.
The newest scored trade: sold $1.9M of PROK on Nov 12, 2025, filed Nov 14, 2025, scored 60 (notable). In the last 12 months: 0 buys worth $0 and 1 sell worth $1.9M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PROK: PROKIDNEY CORP.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | PROKsell PROKIDNEY CORP. | $1.9M 757,162 shares | -112% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 18, 2026 | PROK ProKidney Corp | 81,929 0.04% of outstanding | $114k | Aug 18, 2026 | $314k |
| Aug 18, 2026 | PROK Prokidney Corp | 675,235 0.32% of outstanding | $945k | Aug 18, 2026 | $38k |
| Nov 12, 2025 | PROK ProKidney Corp | 81,928 0.06% of outstanding | $221k | Nov 12, 2025 | $614k |
| Nov 12, 2025 | PROK ProKidney Corp | 675,234 0.48% of outstanding | $1.8M | Nov 12, 2025 | $74k |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -14,000 | - | - | 0 | Jun 11, 2026 |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -7,000 | - | - | 0 | Jun 11, 2026 |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,000 | - | - | 0 | Jun 11, 2026 |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,000 | - | - | 0 | Jun 11, 2026 |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,000 | - | - | 0 | Jun 11, 2026 |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,000 | - | - | 0 | Jun 11, 2026 |
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | - | - | 0 | Jun 11, 2026 |
| May 28, 2026 | PROK PROKIDNEY CORP. | AGrant or award Director stock option (right to buy)derivative | +135,000 | $0.00 | $0 | 135,000 | May 29, 2026 |
| Nov 12, 2025 | PROK PROKIDNEY CORP. | SOpen-market sale Class A Common Stockindirect: By Brian J. G. Pereira 2012 Irrevocable Trust | -227,431 | $2.72 | $619k | 447,803 | Nov 14, 2025 |
| Nov 12, 2025 | PROK PROKIDNEY CORP. | SOpen-market sale Class A Common Stockindirect: Brian J. G. Pereira 2004 Trust | -27,595 | $2.72 | $75k | 54,333 | Nov 14, 2025 |
| Nov 13, 2025 | PROK PROKIDNEY CORP. | SOpen-market sale Class A Common Stockindirect: By Brian J. G. Pereira 2012 Irrevocable Trust | -447,803 | $2.37 | $1.1M | 0 | Nov 14, 2025 |
| Nov 13, 2025 | PROK PROKIDNEY CORP. | SOpen-market sale Class A Common Stockindirect: Brian J. G. Pereira 2004 Trust | -54,333 | $2.37 | $129k | 0 | Nov 14, 2025 |
| Oct 1, 2025 | KALV KalVista Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Oct 2, 2025 |
| May 29, 2025 | PROK PROKIDNEY CORP. | AGrant or award Director stock option (right to buy)derivative | +125,862 | $0.00 | $0 | 125,862 | Jun 2, 2025 |
Questions about Brian JG Pereira
Answered from the filings on this page, as of the latest one.
Is Brian JG Pereira buying or selling?
In the last 12 months Brian JG Pereira reported 0 open-market buys worth $0 and 1 open-market sell worth $1.9M on SEC Form 4; the latest was sold $1.9M of PROK on Nov 12, 2025. Grants, option exercises and tax withholding are not counted.
How did Brian JG Pereira's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brian JG Pereira has 0.
Where does Brian JG Pereira file Form 4?
Brian JG Pereira has filed Form 4 at PROK (PROKIDNEY CORP.); KALV (KalVista Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.